Evidence map›Paper›PMID 23687624›Full record

ArticleCurrent genetic medicine reports2013

Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners.

Amy Swanson, Amy J Sehnert, Sucheta Bhatt

Abstract read
In one paragraph

Article in Current genetic medicine reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Non-invasive Prenatal Testing Using Fetal DNA.Molecular diagnosis & therapy · 2019
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Discrepancy in fetal sex assignment between cell free fetal DNA and ultrasound.Journal of perinatology : official journal of the California Perinatal Association · 2015
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amy SwansonDepartment of Clinical Affairs, Verinata Health, an Illumina Company, 800 Saginaw Drive, Redwood City, CA 94063 USA.
Amy J Sehnert
Sucheta Bhatt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of prenatal genetic testing has exploded with new non-invasive technologies and test options in the past several years. It is challenging for women's healthcare providers to keep up with the multitude of publications and provide patients with the most accurate and up-to-date information possible regarding prenatal testing. In this article, we examine the sequencing technologies that provide the framework for non-invasive prenatal testing (NIPT) and review the major North American NIPT clinical validation studies published in 2011 and 2012. This paper also compares and contrasts the commercially available non-invasive prenatal tests in the United States, discusses clinical implementation recommendations from professional societies and highlights considerations for genetic counseling.

Indexed as

Cell-free DNA (cfDNA)Fetal aneuploidyMassively parallel sequencingNext-generation sequencingNon-invasive prenatal testing (NIPT)PrenatalPrenatal testingSex chromosome aneuploidiesTrisomy 13Trisomy 18Trisomy 21

Identifiers

PMID23687624
PMCPMC3655220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.